For researchers submitting trial data to ClinicalTrials.gov, the Adverse Events module is one of four mandatory results sections. It requires reporting in three primary categories: All-Cause Mortality: A table tracking all deaths that occurred during the study, regardless of cause. Serious Adverse Events (SAEs): A tabular summary of events resulting in death, life-threatening conditions, hospitalization, or significant disability. Other Adverse Events: A table for non-serious events that exceed a specific frequency threshold, such as 5% within any study arm.
Adverse Events Module path is as follows:
Study -> Results Section -> Adverse Events Module -> Event Groups
Study -> Results Section -> Adverse Events Module -> Serious Events
Study -> Results Section -> Adverse Events Module -> Other Events
| Title | Description | Deaths # Affected | Deaths # At Risk | Serious # Affected | Serious # At Risk | Other # Affected | Other # At Risk | View |
|---|---|---|---|---|---|---|---|---|
| CBL-514 320 mg | CBL-514 will be administered via injection into the thigh subcutaneous adipose layer. | 0 | None | 0 | 6 | 6 | 6 | View |
| CBL-514 480 mg | CBL-514 will be administered via injection into the abdomen subcutaneous adipose layer. | 0 | None | 0 | 7 | 7 | 7 | View |
| CBL-514 640 mg | CBL-514 will be administered via injection into the abdomen subcutaneous adipose layer | 0 | None | 1 | 6 | 6 | 6 | View |
| CBL-514 800 mg | CBL-514 will be administered via injection into the abdomen subcutaneous adipose layer | 0 | None | 0 | 6 | 6 | 6 | View |
| Term | Type | Organ System | Vocab | View |
|---|---|---|---|---|
| Closed head injury with post concussive symptoms | SYSTEMATIC_ASSESSMENT | Injury, poisoning and procedural complications | None | View |
| Term | Type | Organ System | Vocab | View |
|---|---|---|---|---|
| Injection site warmth | SYSTEMATIC_ASSESSMENT | General disorders | None | View |
| Injection site erythema | SYSTEMATIC_ASSESSMENT | General disorders | None | View |
| Injection site bruising | SYSTEMATIC_ASSESSMENT | General disorders | None | View |
| Injection site pain | SYSTEMATIC_ASSESSMENT | General disorders | None | View |
| Injection site swelling | SYSTEMATIC_ASSESSMENT | General disorders | None | View |
| Injection site pruritus | SYSTEMATIC_ASSESSMENT | General disorders | None | View |
| Injection site discolouration | SYSTEMATIC_ASSESSMENT | General disorders | None | View |
| Injection site induration | SYSTEMATIC_ASSESSMENT | General disorders | None | View |
| Presyncope | SYSTEMATIC_ASSESSMENT | Nervous system disorders | None | View |